ЗОЛАЦИД

उत्पाद अवलोकन

About ЗОЛАЦИД

ЗОЛАЦИД is a medication containing the active ingredient Zoledronic acid, a bisphosphonate used in the treatment of bone diseases. It is administered intravenously to help prevent skeletal fractures and bone loss in patients with conditions such as osteoporosis, bone metastases, and multiple myeloma.

Key Benefits & Uses

• Prevention of skeletal fractures in patients with osteoporosis
• Treatment of bone metastases and hypercalcemia of malignancy
• Prevention of bone loss in patients with multiple myeloma

Active Ingredient & Action

Zoledronic acid works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone turnover and increasing bone density. It also has a direct effect on bone cells, promoting bone formation and reducing bone destruction.

Important Notes

ЗОЛАЦИД should be administered under the supervision of a healthcare professional. Patients with certain kidney or liver disorders, or those taking certain medications, may require dose adjustments or alternative treatments. It is essential to follow the recommended dosing schedule and to report any adverse reactions or concerns to a healthcare provider.